This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2006 May 20;332(7551):1163-4.

doi: 10.1136/bmj.332.7551.1163.

Ethnicity and adverse drug reactions

PMID: 16709964
PMCID: PMC1463978
DOI: 10.1136/bmj.332.7551.1163

Editorial

Ethnicity and adverse drug reactions

Erik Eliasson. BMJ. 2006.

. 2006 May 20;332(7551):1163-4.

doi: 10.1136/bmj.332.7551.1163.

Author

PMID: 16709964
PMCID: PMC1463978
DOI: 10.1136/bmj.332.7551.1163

No abstract available

PubMed Disclaimer

Comment on

Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine.
McDowell SE, Coleman JJ, Ferner RE. McDowell SE, et al. BMJ. 2006 May 20;332(7551):1177-81. doi: 10.1136/bmj.38803.528113.55. Epub 2006 May 5. BMJ. 2006. PMID: 16679330 Free PMC article. Review.

Similar articles

Ethnically diverse pluripotent stem cells for drug development.
Fakunle ES, Loring JF. Fakunle ES, et al. Trends Mol Med. 2012 Dec;18(12):709-16. doi: 10.1016/j.molmed.2012.10.007. Epub 2012 Nov 9. Trends Mol Med. 2012. PMID: 23142148 Review.
Pharmacogenomics and active surveillance for serious adverse drug reactions in children.
Loo TT, Ross CJ, Sistonen J, Visscher H, Madadi P, Koren G, Hayden MR, Carleton BC. Loo TT, et al. Pharmacogenomics. 2010 Sep;11(9):1269-85. doi: 10.2217/pgs.10.111. Pharmacogenomics. 2010. PMID: 20860467 Review.
Pharmacogenomics of adverse drug reactions: implementing personalized medicine.
Wei CY, Lee MT, Chen YT. Wei CY, et al. Hum Mol Genet. 2012 Oct 15;21(R1):R58-65. doi: 10.1093/hmg/dds341. Epub 2012 Aug 19. Hum Mol Genet. 2012. PMID: 22907657 Review.
[Pharmacogenomics for adverse drug reactions].
Saito Y, Sai K, Sawada J. Saito Y, et al. Nihon Rinsho. 2010 Aug;68 Suppl 8:263-8. Nihon Rinsho. 2010. PMID: 20979280 Review. Japanese. No abstract available.
[Genetic demographic structure of the Lugansk (Ukraine) population: age, ethnicity, education, and occupation].
[No authors listed] [No authors listed] Genetika. 2005 Oct;41(10):1392-9. Genetika. 2005. PMID: 16316012 Russian.

See all similar articles

Cited by

Ethnicity in neuro-oncology research: How are we doing and how can we do better?
Baig Mirza A, Fayez F, Rashed S, Burn L, Evans ZM, Karagozlu Z, Vastani A, Lavrador JP, Vergani F, Gullan R, Bhangoo R, Ashkan K. Baig Mirza A, et al. J Neurooncol. 2024 Nov;170(2):223-233. doi: 10.1007/s11060-024-04769-1. Epub 2024 Sep 24. J Neurooncol. 2024. PMID: 39316318 Free PMC article.
Shining a spotlight on the inclusion of disabled participants in clinical trials: a mixed methods study.
Sakuma Y, Miller MLE, Babalis DS, Baker A, Reddi M, Anjum A, Bruton J, Jones KN, Mulla UZ, Taddese H. Sakuma Y, et al. Trials. 2024 Apr 26;25(1):281. doi: 10.1186/s13063-024-08108-7. Trials. 2024. PMID: 38671497 Free PMC article.
Pharmacokinetics and Safety of the Tyrosine Kinase 2 Inhibitor Deucravacitinib in Healthy Chinese Subjects.
Jing S, Lin Y, Dockens R, Marchisin D, He B, Girgis IG, Chimalakonda A, Murthy B, Aras U. Jing S, et al. Dermatol Ther (Heidelb). 2023 Dec;13(12):3153-3164. doi: 10.1007/s13555-023-01050-7. Epub 2023 Nov 19. Dermatol Ther (Heidelb). 2023. PMID: 37981596 Free PMC article.
Pharmacokinetics, Safety, and Tolerability of Single- and Multiple-Dose Once-Daily Baricitinib in Healthy Chinese Subjects: A Randomized Placebo-Controlled Study.
Zhao X, Sheng XY, Payne CD, Zhang X, Wang F, Cui YM. Zhao X, et al. Clin Pharmacol Drug Dev. 2020 Nov;9(8):952-960. doi: 10.1002/cpdd.868. Epub 2020 Sep 17. Clin Pharmacol Drug Dev. 2020. PMID: 32945153 Free PMC article. Clinical Trial.
Low Body Weight Increases the Risk of Ischemic Stroke and Major Bleeding in Atrial Fibrillation: The COOL-AF Registry.
Krittayaphong R, Chichareon P, Komoltri C, Kornbongkotmas S, Yindeengam A, Lip GYH. Krittayaphong R, et al. J Clin Med. 2020 Aug 22;9(9):2713. doi: 10.3390/jcm9092713. J Clin Med. 2020. PMID: 32842610 Free PMC article.

See all "Cited by" articles

References

1. Foster MW, Sharp RR. Beyond race: towards a whole genome perspective on human populations and genetic variation. Nature Rev Genet 2004;5: 790-5. - PubMed
1. Cooper RS, Kaufman JS, Ward R. Race and genomics. N Engl J Med 2003;348: 1166-70. - PubMed
1. McDowell SE, Coleman JJ, Ferner RE. Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine. BMJ 2006;332: 1177-80. - PMC - PubMed
1. Need AC, Motulsky AG, Goldstein DB. Priorities and standards in pharmacogenetic research. Nature Genetics 2005;37: 671-81. - PubMed
1. Yue Q-Y, Svensson J-O, Sjöqvist F, Säwe J. A comparison of the pharmacokinetics of codeine and its metabolites in healthy Chinsese and Caucasian extensive hydroxylators of debrisoquine. Br J Clin Pharmacol 1991;31: 643-7. - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information